News

Tokyo – September 15, 2026 -- Mercuria Energy Group Limited has closed a new JPY 145.3 billion three-year Samurai term loan facility, refinancing a JPY 130.9 billion facility signed in 2024 and increasing the total commitment by roughly JPY 14.4 billion.

Facility size ranks among largest Samurai loans in market

The JPY 145.3 billion facility will fund general corporate and working capital needs, extending a financing relationship Mercuria has maintained with Japanese lenders since its first Samurai loan in 2014.

Four banks arrange syndication as bookrunning mandated lead arrangers

Credit Agricole Corporate and Investment Bank, Mizuho Bank, MUFG Bank and Sumitomo Mitsui Banking Corporation structured the deal.

Osnabrück – September 15, 2026 -- Germany's Federal Ministry of the Interior has cut budgeted funding for mandatory integration courses to 590 million euros for 2027, down from nearly 1 billion euros in 2026, a reduction of roughly 41%.

Funding cut will finance only 150,000 participants next year

According to the ministry's response to a parliamentary inquiry from the Green Party, obtained by Neue Osnabrücker Zeitung, the 590 million euro allocation for 2027 covers just 150,000 course participants. That compares with more than 400,000 people who completed the courses in 2025; final 2026 enrollment figures have not yet been released.

Miami – September 9, 2026 -- BioEdge Research Labs has begun publishing batch-specific Certificates of Analysis (COAs) directly on its product pages, allowing laboratory customers to verify identity and purity data for the exact lot they receive rather than relying on aggregated supplier summaries.

Each lot now carries its own matched documentation

Instead of a single certificate applied across multiple production runs, every vial supplied by the Miami-based company is assigned a lot number tied to a corresponding COA, letting researchers cross-check the physical material against its specific record.

Independent labs handle identity and purity testing

The underlying analysis is conducted by a third-party laboratory rather than BioEdge itself, covering identity verification via mass spectrometry, purity assessment via high-performance liquid chromatography, and contaminant screening.

Sydney – September 15, 2026 -- First Graphene Limited (ASX: FGR, FRA: M11, OTCQB: FGPHF) has secured its first production purchase order for PureGRAPH® from Australian polyurethane manufacturer Pacific Urethanes Pty Ltd, marking a new customer and a new commercial application for the graphene material.

Pacific Urethanes will incorporate PureGRAPH® into polyurethane formulations to boost fire-retardant performance

The order targets applications for the Australian mining and resources sector, where polyurethane is widely used for screening media, wear liners, slurry systems, conveyor components, pumps, piping, and chute liners due to its abrasion resistance and impact performance. Fire performance has been a recognised limitation of polyurethane, particularly in underground mining environments where fire, smoke and hazardous gases pose safety risks.

London – September 15, 2026 -- Tulip Licensing Ltd has launched Tulip Imaging, a patent licensing program granting implementers access to more than 125,000 patents covering digital imaging and information processing technologies contributed by Canon Inc., Sony Group Corporation, Huawei Technologies Co., Ltd., and Guangdong OPPO Mobile Telecommunications Corp., Ltd.

Four technology giants pool 125,000-plus patents into a single licensing program

The combined portfolio spans decades of research from four of the largest imaging technology developers globally, covering optics, cameras, image processing, computational photography, and artificial intelligence-driven imaging systems. Tulip describes the offering as the most significant consolidation of digital imaging and information processing patents to date, allowing implementers to tailor licenses to specific products and business needs rather than negotiating separately with each patent holder.

Newport Beach, Calif. – September 15, 2026 -- iFlex Stretch Studios, the assisted stretching franchise under Sequel Brands, has integrated Kinotek's markerless 3D movement assessment technology across its studio network, giving certified stretch therapists AI-driven data to personalize client sessions.

Kinotek's markerless system scans clients in seconds without sensors or wearables

The technology captures a client's body in motion before a session begins, analyzing range of motion, symmetry, and movement quality without requiring markers or sensors. Therapists use the resulting data to build personalized stretching plans, recommend at-home mobility work, and suggest recovery products tailored to individual goals.

Las Vegas – September 15, 2026 -- Employees of nonprofit managed care organization CareSource raised $75,000 for The Children's Cabinet of Nevada through the company's 2026 Workplace Giving campaign.

CareSource Foundation directs employee-driven giving toward mental health programs

The contribution stems from CareSource's "Together We Give, Together We Impact" campaign, administered by the CareSource Foundation, which this year focuses on addressing the mental health crisis affecting communities nationwide. The Foundation has awarded more than $39 million to nonprofits since 2006, targeting poverty elimination and healthy-community initiatives for low- and moderate-income families.

Durham – September 15, 2026 -- Seismic Pharmaceuticals has enrolled the first patient in RESCUE HF-CS, a global Phase 3 trial testing istaroxime as a potential first-ever approved drug for heart-failure-related cardiogenic shock, a condition with no FDA-approved treatment.

Trial to enroll 600 patients across four continents

The study will recruit approximately 600 patients at clinical sites in the United States, Europe, China and South America. It builds on four completed Phase 2 trials that enrolled more than 350 patients.

Cardiogenic shock carries high mortality despite critical care advances

The condition occurs when the heart cannot pump enough blood to meet the body's needs, cutting oxygen delivery to vital organs. It often complicates acute heart failure or other serious cardiac events, and no pharmacologic therapy has been developed specifically to treat it.

Mexico City – September 15, 2026 -- Rocío Olea Salgado, a shareholder in Greenberg Traurig's Mexico City office, has been named Co-lead of the Corporate & M&A Commission of the Mexico Chapter of Women in a Legal World (WLW) 2026.

Olea Salgado will drive initiatives to elevate women in corporate and M&A decision-making roles

WLW is an international organization focused on advancing the leadership and participation of women in the legal sector, connecting practitioners across specialties for collaboration, training, and mentorship. In her new role, Olea Salgado will lead efforts to highlight female talent in corporate and M&A practice and expand women's presence in senior legal decision-making within the sector.

Hollywood, Fla. – September 15, 2026 -- Memorial Healthcare System has appointed Atif M. Hussein, M.D., as chief of Memorial Cancer Institute, capping more than 25 years of physician leadership at the South Florida cancer program.

Hussein built the institute from a handful of oncologists into a comprehensive cancer network

Recruited from Duke University more than two decades ago, Dr. Hussein joined Memorial when its oncology staff was minimal. He since expanded multidisciplinary care, clinical research and graduate medical education, while recruiting nationally recognized physicians to the program.